Financial Gravity Asset Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$902.69 - $993.35 $902 - $993	-1 Reduced 50.0%	1 $1.13 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $902 - $993	1 Added 50.0%	3 $2.99 Million
Q4 2023 Jun 26, 2024	SELL	$775.18 - $881.7 $775 - $881	-1 Reduced 33.33%	2 $3.03 Million
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $496,486 - $605,413	-717 Reduced 99.72%	2 $1,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $72,103 - $85,526	-103 Reduced 12.53%	719 $1.96 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $68,729 - $83,523	101 Added 14.01%	822 $3.04 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $5.33 Million - $5.78 Million	-7,547 Reduced 91.28%	721 $2.42 Million
Q3 2022 Nov 03, 2022	SELL	$573.97 - $724.32 $5.43 Million - $6.85 Million	-9,462 Reduced 53.37%	8,268 $2.55 Million
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $1.76 Million - $2.37 Million	-3,210 Reduced 15.33%	17,730 $4.36 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $7.57 Million - $8.89 Million	12,724 Added 154.87%	20,940 $5.47 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $4.46 Million - $5.51 Million	8,212 Added 205300.0%	8,216 $2.36 Million
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $945 - $1,117	-2 Reduced 33.33%	4 $559,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $7,147 - $8,771	-16 Reduced 72.73%	6 $2.62 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $10,522 - $13,375	22 New	22 $10,000
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $74,491 - $97,231	-151 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $34,626 - $50,926	-103 Reduced 40.55%	151 $73,000
Q4 2019 Feb 28, 2020	SELL	$274.13 - $376.51 $35,088 - $48,193	-128 Reduced 33.51%	254 $375,000
Q3 2019 Oct 15, 2019	SELL	$273.46 - $318.39 $23,244 - $27,063	-85 Reduced 18.2%	382 $106,000
Q2 2019 Jul 26, 2019	SELL	$299.6 - $414.82 $29,960 - $41,482	-100 Reduced 17.64%	467 $146,000
Q1 2019 Apr 19, 2019	SELL	$372.08 - $439.57 $39,068 - $46,154	-105 Reduced 15.63%	567 $232,000
Q3 2018 Oct 31, 2018	BUY	$351.14 - $408.51 $35,465 - $41,259	101 Added 17.69%	672 $226,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $40,697 - $49,333	-143 Reduced 20.03%	571 $211,000
Q1 2018 May 23, 2018	BUY	$315.82 - $393.78 $225,495 - $281,158	714 New	714 $211,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account